S. Cheng

21.3k total citations
9 papers, 6 citations indexed

About

S. Cheng is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, S. Cheng has authored 9 papers receiving a total of 6 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cancer Research, 4 papers in Pulmonary and Respiratory Medicine and 4 papers in Oncology. Recurrent topics in S. Cheng's work include Cancer Genomics and Diagnostics (7 papers), Lung Cancer Treatments and Mutations (2 papers) and Sarcoma Diagnosis and Treatment (1 paper). S. Cheng is often cited by papers focused on Cancer Genomics and Diagnostics (7 papers), Lung Cancer Treatments and Mutations (2 papers) and Sarcoma Diagnosis and Treatment (1 paper). S. Cheng collaborates with scholars based in China, Italy and United States. S. Cheng's co-authors include Yaobin Lin, Shifu Chen, Chen Du, Yuguang Wang, Yanqing Zhou, Yu Guo, Zhi Zheng, Yong Huang, Gui Geng and Yujun Zhou and has published in prestigious journals such as Journal of Clinical Oncology, Medicine and Journal of Plant Physiology.

In The Last Decade

S. Cheng

4 papers receiving 6 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
S. Cheng China	2	3	3	3	2	1	9	6
Xiaohua Liang China	2	3 1.0×	3 1.0×				3	6
João Oliveira Portugal	2	3 1.0×	3 1.0×				5	7
Mano Joseph United States	2	3 1.0×	3 1.0×				3	5
Smruti Koppikar India	2	3 1.0×	3 1.0×				3	4
Giuliano Borda‐Luque Peru	1	3 1.0×	3 1.0×				3	4
Aurore Vozy France	2	3 1.0×	3 1.0×				4	5
Jyri Teras Estonia	2	3 1.0×	4 1.3×				3	5
Gayathri Prakash Pakistan	1	3 1.0×	2 0.7×				2	4
Dylan Domenico United States	2	3 1.0×	2 0.7×				7	6
Kristen E. Lowder United States	2	3 1.0×	2 0.7×				4	5

Countries citing papers authored by S. Cheng

Since Specialization

Citations

This map shows the geographic impact of S. Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Cheng more than expected).

Fields of papers citing papers by S. Cheng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Cheng. The network helps show where S. Cheng may publish in the future.

Co-authorship network of co-authors of S. Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of S. Cheng. A scholar is included among the top collaborators of S. Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Cheng. S. Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Zhou, Yuheng, et al.. (2024). Investigation of the role of personalized molecular residual disease in the assessment of high-risk non-small cell lung cancer (NSCLC) post-operation.. Journal of Clinical Oncology. 42(16_suppl). 8027–8027.

2.

Yao, Ping, et al.. (2024). Lung adenocarcinoma with brain metastasis detected dual fusion of LOC399815-ALK and ALK-EML4 in combined treatment of Alectinib and CyberKnife: A case report. Medicine. 103(3). e36992–e36992. 1 indexed citations

3.

Yang, Zuoquan, Yanqing Zhou, Yaru Chen, et al.. (2024). Analytical and clinical validation of a personalized, tumor-informed circulating tumor DNA assay for minimal residual disease detection.. Journal of Clinical Oncology. 42(16_suppl). e14545–e14545.

4.

Gong, Fan, et al.. (2024). Co-optimized Scheduling of Multi-Microgrids and Active Distribution Network Considering Leasing Shared Energy Storage. 1–6.

5.

Xue, Wei, et al.. (2024). A study on the value of ctDNA-based molecular residual disease (MRD) in dynamic monitoring in the clinical treatment of advanced/metastatic renal cell carcinoma.. Journal of Clinical Oncology. 42(16_suppl). e16522–e16522.

6.

Guo, Yu, et al.. (2024). Value of ctDNA-based molecular residual disease (MRD) in evaluating the adjuvant therapy effect in ovarian cancer.. Journal of Clinical Oncology. 42(16_suppl). 5525–5525.

7.

Wang, Wei, Wenting Liao, Chen Du, et al.. (2023). A study of tumor neoantigen burden and HLA-LOH by whole-exome sequencing to characterize immune biomarkers of lung cancer.. Journal of Clinical Oncology. 41(16_suppl). 8527–8527. 1 indexed citations

8.

Zheng, Zhi, et al.. (2023). Genomic characterization of MSI-H and TMB in gastrointestinal cancer.. Journal of Clinical Oncology. 41(16_suppl). e15524–e15524. 1 indexed citations

9.

Wang, Gang, Piergiorgio Stevanato, Chunhua Lv, et al.. (2022). Growth status and physiological changes of sugar beet seedlings in response to acidic pH environments. Journal of Plant Physiology. 277. 153771–153771. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact